APA (7th ed.) Citation

Ming, W., Huang, X., Weng, X., Lin, S., Liu, Y., Luo, S., . . . Huang, P. Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: A cost-effectiveness analysis. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Ming, Wai-kit, Xiaoting Huang, Xiuhua Weng, Shen Lin, Yiwei Liu, Shaohong Luo, Hang Wang, and Pinfang Huang. Half-dose Fulvestrant Plus Anastrozole as a First-line Treatment for Hormone Receptor-positive Metastatic Breast Cancer: A Cost-effectiveness Analysis. BMJ Publishing Group.

MLA (9th ed.) Citation

Ming, Wai-kit, et al. Half-dose Fulvestrant Plus Anastrozole as a First-line Treatment for Hormone Receptor-positive Metastatic Breast Cancer: A Cost-effectiveness Analysis. BMJ Publishing Group.